Recent Finacing
Recent Raise
EvolveImmune develops immuno-oncology biologics using an EVs platform that targets tumor cells and amplifies localized cytokine secretion to sustain immune activation within the tumor microenvironment.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at EvolveImmune Therapeutics.
